3 Results for "

p-CaMKII

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "p-CaMKII" in MCE Product Catalog:

Cat. No.: HY-B0615AS
CAS No.: 2300178-76-9
Synonyms: EN 313-d8; Ethmozin-d8; Moracizine-d8
Moricizine-d8 Hydrochloride (EN 313-d8; Ethmozin-d8; Moracizine-d8) is the deuterated-labeled Moricizine Hydrochloride (HY-B0615A). Moricizine Hydrochloride (EN 313) is an orally active cardiac sodium channel blocker. Moricizine Hydrochloride blocks inactivated sodium channels in a slow dissociation manner, inhibiting late and peak sodium currents, p-CaMKII, atrial enlargement, and cardiac hypertrophy. Moricizine Hydrochloride can be used in research on atrial fibrillation and arrhythmias .
loading...
    loading...
Cat. No.: HY-B0615A
CAS No.: 29560-58-5
Synonyms: EN 313; Ethmozin; Moracizine
Target:  

Sodium Channel

Research Areas:  

Cardiovascular Disease

Moricizine Hydrochloride (EN 313) is an orally active cardiac sodium channel blocker. Moricizine Hydrochloride blocks inactivated sodium channels in a slow dissociation manner, inhibiting late and peak sodium currents, p-CaMKII, atrial enlargement, and cardiac hypertrophy. Moricizine Hydrochloride can be used in research on atrial fibrillation and arrhythmias .
loading...
    loading...
Cat. No.: HY-163978
CAS No.: 1350113-04-0
Target:  

Adenosine Receptor

Research Areas:  

Neurological Disease

YGZ-331 is a sedative with a calming effect. YGZ-331 is a derivative of the adenosine nucleoside NGBA, which can increase GABA levels. YGZ-331 exerts a sedative-hypnotic effect by activating A1R and A2aR, and inhibiting CaMKII phosphorylation (pCaMKII) levels. YGZ-331 can reduce the spontaneous motor activity of mice .
loading...
    loading...